Drug Discovery pp 377-388 | Cite as

Chenodeoxycholic Acid and Ursodeoxycholic Acid

  • Robert A. Maxwell
  • Shohreh B. Eckhardt

Abstract

Cholelithiasis (gallstones) is a major medical and economic problem in the USA (Schoenfield, 1977; Schoenfield et al., 1981). It has been estimated to have a prevalence of 15 million women and five million men, and almost one million new cases are discovered each year (Ingelfinger, 1968; Friedman et al., 1966). Gallstones account for 5000–8000 deaths and a toll of $1 billion annually (Schoenfield et al, 1981).

Keywords

Cholesterol Diarrhea Gall Lactose Constipation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramowicz, M., ed.: Chenodiol for dissolving gallstones. Medical Letter 25:101,102,1983.Google Scholar
  2. Admirand, W. H. and Small, D.M.: The physicochemical basis of cholesterol gallstone formation in man. J. Gin. Invest. 47:1043–1052, 1968.Google Scholar
  3. Andrews, E., Schoenheimer, R., and Hrdina, L.: Etiology of gall stones. II. Role of the gallbladder. Proc. Soc. Exp. Biol. Med. 28:945,946,1931a.Google Scholar
  4. Andrews, E., Schoenheimer, R., and Hrdina, L.: Etiology of gall stones. III. Bile salt-cholesterol ratio in human gall stone cases. Proc. Soc. Exp. Biol. Med. 28: 945–948, 1931b.Google Scholar
  5. Andrews, E., Dostal, L. E., Goff, M., and Hrdina, L.: The mechanism of cholesterol gallstone formation. Ann. Surg. 96:615–623, 1932.PubMedCrossRefGoogle Scholar
  6. Bachrach, W. H. and Hof mann, A. F.: Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis Part I. Dig. Dis. Sci. 27:737–761, 1982.PubMedCrossRefGoogle Scholar
  7. Budavari, S., ed.: The Merck Index, 11th Ed., p. 1556, Merck & Co., Rahway, NJ, 1989.Google Scholar
  8. Cole, W. H. and Harridge, W. H.: Disappearance of “stone” shadows in post-operative cholangiograms. JAMA 164: 238–243, 1957.CrossRefGoogle Scholar
  9. Danziger, R. G., Hofmann, A. F., Schoenfield, L. J., and Thistle, J. L.: Dissolution of cholesterol gallstones by chenodeoxycholic acid. N. Engl. J. Med. 286:1–8, 1972.CrossRefGoogle Scholar
  10. Fedorowski, T., Salen, G., Tint, G. S., and Mosbach, E.: Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterohgy 77:1068–1073, 1979.Google Scholar
  11. Friedman, G. D., Kannel, W. B., and Dawber, T. R.: The epidemiology of gallbladder disease: Observations in the Framingham study. J. Chronic Dis. 19:273–292, 1966.PubMedCrossRefGoogle Scholar
  12. Hammarsten, O.: Zur Chemie der Galle. Ergeh. Physiol. 4:1–22, 1905.Google Scholar
  13. Ingelfinger, F. J.: Digestive disease as a national problem. V. Gallstones. Gastroenterohgy 55:102–104, 1968.Google Scholar
  14. Isaksson, B.: On the lipid constituents of normal bile. ActaSoc.Med.Upsala 56:177–195, 1951.Google Scholar
  15. Isaksson, B.: On the lipid constituents of bile from human gallbladder containing cholesterol gallstones. A comparison with normal humanbladder bile. Ada Soc. Med. Upsala 59:277–295, 1954a.Google Scholar
  16. Isaksson, B.: On the dissolving power of lecithin and bile salts for cholesterol in human bladder bile. Ada Soc. Med. Upsala 59:296–306, 1954b.Google Scholar
  17. Johnston, C. G., Irvin, J. L., and Walton, C: The free choline and phospho-lipid of hepatic and gallbladder bile. J. Biol. Chem. 131:42S437,1939.Google Scholar
  18. Linos, D. A., Beard, C. M., O’Fallon, W. M., Dockerty, M. B., Beart, R. W. Jr., and Kurland, L. T.: Cholecystectomy and carcinoma of the colon. Lancet 2:379–381, 1981.PubMedCrossRefGoogle Scholar
  19. Long, J. H. and Gephart, F.: On the behavior of lecithin with bile salts, and the occurrence of lecithin in bile. J. Am. Chem. Soc. 30:1312–1319, 1908.CrossRefGoogle Scholar
  20. Makino, I., Shinozaki, K., Yoshino, K., and Nakagawa, S.: Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn. J. Gastroenterol. 72: 690–702, 1975.Google Scholar
  21. Maton, P. N., Murphy, G. M., and Dowling, R. H.: Ursodeoxycholic acid treatment of gallstones. Lancet 2:1297–1301, 1977.PubMedCrossRefGoogle Scholar
  22. Nakagawa, S., Makino, I., Ishizaki, T., and Dohi, I.: Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 2:367–369, 1977.PubMedCrossRefGoogle Scholar
  23. Nakayama, F.: Oralcholelitholysis—cheno versus urso. Japanese experience. Dig. Dis. Sci. 25:129–134, 1980.PubMedCrossRefGoogle Scholar
  24. Rains, A. J. H.: Gallstones, Causes and Treatment, Charles C. Thomas, Springfield, IL, 1964.Google Scholar
  25. Rewbridge, A. G.: The disappearance of gallstone shadows following the prolonged administration of bile salts. Surgery 1:395–400, 1937.Google Scholar
  26. Rosenak, B. D. and Kohlstaedt, K. G.: Bile salt therapy in liver and gall bladder disease. Am. J. Dig. Dis. Nutr. 3:577–580, 1936.CrossRefGoogle Scholar
  27. Salen, G., Tint, G. S., Eliav, B., Deering, N., and Mosbach, E. H.: Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid. J. Clin. Invest. 53:612–621, 1974.PubMedCrossRefGoogle Scholar
  28. Schoenfield, L. J.: Diseases of the Gallbladder and Biliary System, Wiley, New York, 1977.Google Scholar
  29. Schoenfield, L. J., Lachin, J. M., The Steering Committee, and The National Cooperative Gallstone Study Group: Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The national cooperative gallstone study. Ann. Intern. Med. 95:257–282, 1981.PubMedGoogle Scholar
  30. Schoenheimer, R. and Hrdina, L.: The etiology of gall stones. I. Chemical factors. Proc. Soc. Exp. Biol. Med. 28:944,945,1931.Google Scholar
  31. Spanner, G. O. and Bauman, L.: The behavior of cholesterol and other bile constituents in solutions of bile salts. J. Biol. Chem. 98:181–183, 1932.Google Scholar
  32. Stiehl, A., Czygan, P., Kommerell, B., Weis, H. J., and Holtermuller, K. H.: Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones. Gastroenterology 75:1016–1020, 1978.PubMedGoogle Scholar
  33. Thistle, J. L. and Hofmann, A. F.: Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. N. Engl. J. Med. 289:655–659, 1973.PubMedCrossRefGoogle Scholar
  34. Thistle, J. L. and Schoenfield, L. J.: Induced alterations in composition of bile of persons having cholelithiasis. Gastroenterology 61:488–496, 1971.PubMedGoogle Scholar
  35. Tint, G. S., Salen, G., and Shefer, S.: Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. Gastroenterology 91:1007–1018, 1986.PubMedGoogle Scholar
  36. Tint, G. S., Salen, G., Colalillo, A., Graber, D., Verga, D., Speck, J., and Shefer, S.: Ursodeoxycholic acid: A safe and effective agent for dissolving cholesterol gallstones. Ann. Intern. Med. 97:351–356, 1982.PubMedGoogle Scholar
  37. Tokyo Cooperative Gallstone Study Group: Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Gastroenterology 78:542–548, 1980.Google Scholar
  38. Vernick, L. J. and Kuller, L. H.: Cholecystectomy and right-sided colon cancer: An epidemiological study. Lancet 2:381–383, 1981PubMedCrossRefGoogle Scholar
  39. Vlahcevic, Z. R., Bell, C. C., Buhac, I., Farrar, J. T., and Swell, L.: Diminished bile acid pool size in patients with gallstones. Gastroenterology 59: 165–173, 1970.PubMedGoogle Scholar
  40. Ward, A., Brogden, R. N., Heel, R. C., Speight, T. M., and Avery, G. S.: Ursodeoxycholic acid. A review of its pharmacological properties and therapeutic efficacy. Drugs 27:95–131, 1984.PubMedCrossRefGoogle Scholar
  41. White, B. A., Fricke, R. J., and Hylemon, P. B.: 7β-Dehydroxylation of ursodeoxycholic acid by whole cells and cell extracts of the intestinal anaerobic bacterium, Eubacterium species V.P.I. 12708. J. Lipid Res. 23:145–153, 1982.Google Scholar
  42. Wieland, H. and Reverey, G.: Untersuchungen über Gallensäuren. XXI. Mitteilung. Zur Kenntnis der menschlichen Galle, 1. Z. Physiol. Chem. 140:186–202, 1924.CrossRefGoogle Scholar
  43. Windhaus, A., Bohne, A., and Schwarzkopf, E.: Über die Cheno-desoxy-cholsäure. Z. Physiol. Chem. 140:177–185, 1924.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Robert A. Maxwell
    • 1
  • Shohreh B. Eckhardt
    • 2
  1. 1.The Wellcome Research Laboratories ResearchTriangle ParkUSA
  2. 2.University of Vermont College of MedicineBurlingtonUSA

Personalised recommendations